Moderate-to-Severe Acne Therapeutics Market Pipeline & Innovation
According to FutureWise analysis the market for moderate-to-severe acne therapeutics in 2026 is US$ 1.59 billion, and is expected to reach US$ 2.68 billion by 2036 at a CAGR of 5.36%. Market growth is fueled by the rising cases of persistent acne, more dermatology consultations, and increased awareness of early intervention. The development of novel biologics, combination therapies, and...
0 Commenti 0 condivisioni 107 Views 0 Anteprima
Sponsorizzato